Randomized, Double-Blind, Multicenter, Phase 3 Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
Randomized, Double-Blind, Multicenter, Phase 3 Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
The purpose of this study is to evaluate the safety and efficacy of the addition of veliparib plus carboplatin and paclitaxel versus the addition of placebo plus carboplatin and paclitaxel in adults with advanced or metastatic squamous non-small cell lung cancer (NSCLC).
Inclusion Criteria:
Exclusion Criteria:
Jacksonville, Florida 32256, United States
Evanston, Illinois 60201, United States
Lansing, Michigan 48912, United States
Lincoln, Nebraska 68510, United States
Hershey, Pennsylvania 17033, United States
Dallas, Texas 75246-2003, United States
Lesnoy, 223040, Belarus
Itajaí, Santa Catarina 88301-220, Brazil
Rio de Janeiro, 20231-050, Brazil
Nea Efkarpia, Thessaloniki 54603, Greece
Miskolc, Borsod-Abauj Zemplen county 3529, Hungary
Budapest XII, Budapest 1122, Hungary
Kékesteto, 3233, Hungary
Perugia, 06100, Italy
Kaunas, Kaunas County 50009, Lithuania
Wellington, 6021, New Zealand
Rzeszów, Podkarpackie Voivodeship 35-021, Poland
Guimarães, Braga District 4835-044, Portugal
Moscow, Moscow 115478, Russia
Yekaterinburg, Sverdlovsk Oblast 620043, Russia
Volgograd, Volgograd Oblast 400138, Russia
Irkutsk, 664035, Russia
Murmansk, 183047, Russia
Tomsk, 634050, Russia
Pieštany, 921 01, Slovakia
Istanbul, 34098, Turkey (Türkiye)
Kharkiv, Kharkiv Oblast 61070, Ukraine
Chernivtsi, 58013, Ukraine
Dnipro, 49102, Ukraine
Poltava, 36011, Ukraine
Sumy, 40022, Ukraine